|
⚲
|
| Keyboard |
| McCulloch Kevin
✚
|
|
|---|---|
| CIK # | 0002031695 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002031695] | |
| 4 | [0002031695] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xeris Biopharma Holdings Inc | |
| McCulloch Kevin |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-03-12 | Option exercise | 4 | $3.94 | 16 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-03-12 | Option exercise | 4 | $3.94 | 16 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-03-12 | Option exercise | 48,894 | $4.09 | 199,976 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-03-12 | Option exercise | 48,894 | $4.09 | 199,976 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 68,454 | $7.36 | 503,821 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 30,289 | $7.36 | 222,927 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 27,319 | $7.36 | 201,068 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-01-30 | Grant | 225,225 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-30 | Grant | 168,463 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-08 | Sell | 15,000 | $8.00 | 120,000 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-10-02 | Tax withheld | 733 | $8.31 | 6,091 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-08-01 | Tax withheld | 14,651 | $5.38 | 78,822 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-06-13 | Buy | 25,000 | $4.38 | 109,500 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-04-02 | Tax withheld | 733 | $5.15 | 3,775 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Tax withheld | 29,300 | $3.56 | 104,308 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Tax withheld | 48,834 | $3.56 | 173,849 |
|
Xeris Biopharma Holdings Inc XERS
Stock Appreciation Right · derivative
|
2025-01-31 | Grant | 500,000 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Grant | 185,000 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-03 | Tax withheld | 24,501 | $3.61 | 88,449 |
|
Xeris Biopharma Holdings Inc XERS
Stock Appreciation Right · derivative
|
2024-08-01 | Grant | 200,000 | $0.00 | |
| showing 20 of 21 most recent transactions | |||||